Lymphedema Treatment Market Recent Study Including Growth Factors CAGR of 4.0% by 2027: Applications, Regional Analysis
Research Reports
Apr 13, 2022
MRFR (Market Research Future) says that the lymphedema treatment market can expect to gain traction at a rate of 4.0% from 2020 to 2027 (analysis period).
Lymphedema is a serious condition that involves lymph fluid accumulating in the fatty tissues present underneath the skin. The condition develops when the flow in the lymphatic system is impaired, occurring in the arms or legs or even both of them. The disease can also affect the neck, abdomen, face or genitals of the person, depending on the location of the body that has received the treatment. Primary lymphedema occurs right at birth, on the other hand, secondary lymphedema develops because of damage or dysfunction of the lymphatic system.
Cancer-based treatment remains the major reason for secondary lymphedema. Radiation therapy, surgery, or even the cancer itself curbs the lymph fluid’s flow, which results in lymphedema. Symptoms include feeling of heaviness or tightness; swelling in the arms, legs, or various other parts; discomfort or ache; fibrosis.
Rigorous research activities to develop advanced novel therapies for treating lymphedema is bound to enhance the market size in the following years. The surging burden of cancer; rise in technological developments in diagnostic imaging modalities; and growth in funds, grants, and investments by public-private organizations as well as governments worldwide can ensure steady market expansion as well.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8440
.jpg?1649854142905)
Market Segmentation
Lymphedema types are secondary and primary. As the patient pool affected by secondary lymphedema continues to expand, the segment is touted to grab the leading spot in the years to come.
Affected areas covered in the report are genitalia, upper extremity, lower extremity and more. Upper extremity is the most affected area by the disease, elevating the segment’s position to the top in the global market.
Treatment-wise, major segments can be laser therapy, compression device and bandaging, drug therapy and surgery and more.
End-users of lymphedema treatment include research and academic institutes, hospitals and clinics, clinical research organizations and more.
Regional Insight
America shall emerge as the global leader during the conjectured period, given the mounting cases of lymphedema and the surging focus on using genetic therapy as a key treatment method. Escalating deployment of cutting-edge technologies during the treatment, mounting number of medical facilities bolster the market value in the region. Strong presence of a well-developed healthcare industry and the expansive population of board-certified, and skilled medical professionals will benefit the American industry in the future.
Asia Pacific can expect to capture the fastest growth rate in the forthcoming years, thanks to the rapid surge in cases of lymphedema and the subsequent increase in the need for effective treatment methods. India, Japan, Australia, South Korea, and China head the Asia Pacific market, as a result of the booming population of skilled medical professionals, emergence of sophisticated techniques, coupled with cheaper priced treatment options. China and India house a huge elderly population that are affected by the condition. Additionally, the surge in people’s disposable incomes and the thriving medical tourism industry in the region are major growth boosters for the lymphedema market.
Top Firms
The eminent lymphedema treatment solutions and devices companies listed in the MRFR study include Wright Therapy Products (BSN Medical) (Germany), Tactile Systems Technology Inc. (US), Devon Medical Products (US), 3A Health Care (Italy), Bio Compression Systems, Inc. (US), SIGVARIS (Switzerland), Lohmann & Rauscher (Germany), HERANTIS PHARMA PLC (Finland), Mego Afek Ltd (US), and many others.
Latest Developments
September 2021
ImpediMed Limited, a renowned medical technology firm that uses bioimpedance spectroscopy (BIS) to produce useful data that boosts patient health, has introduced Lymphedema Can’t. It is a healthcare campaign that focuses on educating breast cancer survivors and patients regarding the significance of early detection and treatment of lymphedema. The patients are encouraged to learn about the risks associated with lymphedema and go for virtual events headed by advocates for support. Patients can communicate with their physician about lymphedema’s early detection, monitoring, and ways to prevent and deal with the disease.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/lymphedema-treatment-market-8440
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact Information:
Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America +1 646 845 9312 Email: sales@marketresearchfuture.com
Tags:
PR-Wirein, Wire, Research Newswire, English